Serveur d'exploration sur le patient édenté

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Histological observations on biopsies harvested following sinus floor elevation using a bioactive glass material of narrow size range.

Identifieur interne : 002D22 ( PubMed/Checkpoint ); précédent : 002D21; suivant : 002D23

Histological observations on biopsies harvested following sinus floor elevation using a bioactive glass material of narrow size range.

Auteurs : E S Tadjoedin [Pays-Bas] ; G L De Lange ; P J Holzmann ; L. Kulper ; E H Burger

Source :

RBID : pubmed:11168226

Descripteurs français

English descriptors

Abstract

We evaluated the bone augmenting capacity of bioactive glass particles, size range 300-355 microns (BG-particles), in human sinus floor elevations using histomorphometrical methods. A total of 10 patients underwent bilateral grafting, using a 1:1 mixture of autogenous bone particles (from iliac crest) and BG-particles at one side (experimental side), and bone particles only at the other side (control side, split mouth design). A total of 72 bone biopsies were taken at the time of fixture installation; that is, 3 patients at 4 months, 3 at 5 months and 3 at 6 months after grafting and 1 patient at 16 months (when she presented again). In each case 6 biopsies were taken, 3 left and 3 right. Histomorphometry showed that in grafts at control sides, trabecular bone was present after 4 months, comprising almost 41% of the tissue volume. This bone contained viable osteocytes and was of mature lamellar type and showed a mature histological appearance. Bone volume continued to increase slightly, to 42% at 5 months, 44% at 6 months and 45% at 16 months. The graft volume at experimental sides consisted at 4 months for 28% of woven and some lamellar bone, and increased to 35% at 5 months and 38% at 6 months, when mainly lamellar bone was found. At 16 months a lamellar bone volume of 45% was found. The BG-particles transformed and became excavated with time, starting at 4 months, and their centers gradually filled with bone tissue. All BG-particles had disappeared by resorption at 16 months after grafting and had been replaced by bone tissue. Parameters of bone turnover (% osteoid surface, % resorption surface, mineral apposition rate as measured by tetracycline labeling) indicated that bone remodeling was very active at both sides, during more than 6 months, despite the mature histological appearance of the bone tissue. From these histological observations, we conclude that a 1:1 mixture of autogenous bone/BG-particles seems a promising alternative to autogenous bone only, when low amounts of bone tissue are available for sinus augmentation.

PubMed: 11168226


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:11168226

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Histological observations on biopsies harvested following sinus floor elevation using a bioactive glass material of narrow size range.</title>
<author>
<name sortKey="Tadjoedin, E S" sort="Tadjoedin, E S" uniqKey="Tadjoedin E" first="E S" last="Tadjoedin">E S Tadjoedin</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Oral Cell Biology, Academic Center for Dentistry Amsterdam (ACTA), Vrije Universiteit, Amsterdam, van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Oral Cell Biology, Academic Center for Dentistry Amsterdam (ACTA), Vrije Universiteit, Amsterdam, van der Boechorststraat 7, 1081 BT, Amsterdam</wicri:regionArea>
<placeName>
<settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="De Lange, G L" sort="De Lange, G L" uniqKey="De Lange G" first="G L" last="De Lange">G L De Lange</name>
</author>
<author>
<name sortKey="Holzmann, P J" sort="Holzmann, P J" uniqKey="Holzmann P" first="P J" last="Holzmann">P J Holzmann</name>
</author>
<author>
<name sortKey="Kulper, L" sort="Kulper, L" uniqKey="Kulper L" first="L" last="Kulper">L. Kulper</name>
</author>
<author>
<name sortKey="Burger, E H" sort="Burger, E H" uniqKey="Burger E" first="E H" last="Burger">E H Burger</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:11168226</idno>
<idno type="pmid">11168226</idno>
<idno type="wicri:Area/PubMed/Corpus">003669</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003669</idno>
<idno type="wicri:Area/PubMed/Curation">003669</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003669</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003669</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003669</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Histological observations on biopsies harvested following sinus floor elevation using a bioactive glass material of narrow size range.</title>
<author>
<name sortKey="Tadjoedin, E S" sort="Tadjoedin, E S" uniqKey="Tadjoedin E" first="E S" last="Tadjoedin">E S Tadjoedin</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Oral Cell Biology, Academic Center for Dentistry Amsterdam (ACTA), Vrije Universiteit, Amsterdam, van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Oral Cell Biology, Academic Center for Dentistry Amsterdam (ACTA), Vrije Universiteit, Amsterdam, van der Boechorststraat 7, 1081 BT, Amsterdam</wicri:regionArea>
<placeName>
<settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="De Lange, G L" sort="De Lange, G L" uniqKey="De Lange G" first="G L" last="De Lange">G L De Lange</name>
</author>
<author>
<name sortKey="Holzmann, P J" sort="Holzmann, P J" uniqKey="Holzmann P" first="P J" last="Holzmann">P J Holzmann</name>
</author>
<author>
<name sortKey="Kulper, L" sort="Kulper, L" uniqKey="Kulper L" first="L" last="Kulper">L. Kulper</name>
</author>
<author>
<name sortKey="Burger, E H" sort="Burger, E H" uniqKey="Burger E" first="E H" last="Burger">E H Burger</name>
</author>
</analytic>
<series>
<title level="j">Clinical oral implants research</title>
<idno type="ISSN">0905-7161</idno>
<imprint>
<date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Absorbable Implants</term>
<term>Biocompatible Materials (chemistry)</term>
<term>Biocompatible Materials (therapeutic use)</term>
<term>Biopsy</term>
<term>Bone Matrix (pathology)</term>
<term>Bone Remodeling (physiology)</term>
<term>Bone Resorption (pathology)</term>
<term>Bone Substitutes (chemistry)</term>
<term>Bone Substitutes (therapeutic use)</term>
<term>Bone Transplantation (methods)</term>
<term>Dental Implantation, Endosseous</term>
<term>Dental Implants</term>
<term>Female</term>
<term>Fluorescent Dyes</term>
<term>Follow-Up Studies</term>
<term>Glass (chemistry)</term>
<term>Humans</term>
<term>Jaw, Edentulous (surgery)</term>
<term>Maxilla (surgery)</term>
<term>Maxillary Sinus (pathology)</term>
<term>Maxillary Sinus (surgery)</term>
<term>Middle Aged</term>
<term>Osteocytes (pathology)</term>
<term>Osteogenesis (physiology)</term>
<term>Tetracycline</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Biopsie</term>
<term>Colorants fluorescents</term>
<term>Femelle</term>
<term>Humains</term>
<term>Implant résorbable</term>
<term>Implants dentaires</term>
<term>Matériaux biocompatibles ()</term>
<term>Matériaux biocompatibles (usage thérapeutique)</term>
<term>Maxillaire ()</term>
<term>Mâchoire édentée ()</term>
<term>Ostéocytes (anatomopathologie)</term>
<term>Ostéogenèse (physiologie)</term>
<term>Pose d'implant dentaire endo-osseux</term>
<term>Remodelage osseux (physiologie)</term>
<term>Résorption osseuse (anatomopathologie)</term>
<term>Sinus maxillaire ()</term>
<term>Sinus maxillaire (anatomopathologie)</term>
<term>Substituts osseux ()</term>
<term>Substituts osseux (usage thérapeutique)</term>
<term>Trame osseuse (anatomopathologie)</term>
<term>Transplantation osseuse ()</term>
<term>Tétracycline</term>
<term>Verre ()</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Biocompatible Materials</term>
<term>Bone Substitutes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Biocompatible Materials</term>
<term>Bone Substitutes</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Ostéocytes</term>
<term>Résorption osseuse</term>
<term>Sinus maxillaire</term>
<term>Trame osseuse</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Glass</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Bone Transplantation</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Bone Matrix</term>
<term>Bone Resorption</term>
<term>Maxillary Sinus</term>
<term>Osteocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Ostéogenèse</term>
<term>Remodelage osseux</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Bone Remodeling</term>
<term>Osteogenesis</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Jaw, Edentulous</term>
<term>Maxilla</term>
<term>Maxillary Sinus</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Matériaux biocompatibles</term>
<term>Substituts osseux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Absorbable Implants</term>
<term>Biopsy</term>
<term>Dental Implantation, Endosseous</term>
<term>Dental Implants</term>
<term>Female</term>
<term>Fluorescent Dyes</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Tetracycline</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Biopsie</term>
<term>Colorants fluorescents</term>
<term>Femelle</term>
<term>Humains</term>
<term>Implant résorbable</term>
<term>Implants dentaires</term>
<term>Matériaux biocompatibles</term>
<term>Maxillaire</term>
<term>Mâchoire édentée</term>
<term>Pose d'implant dentaire endo-osseux</term>
<term>Sinus maxillaire</term>
<term>Substituts osseux</term>
<term>Transplantation osseuse</term>
<term>Tétracycline</term>
<term>Verre</term>
<term>Études de suivi</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We evaluated the bone augmenting capacity of bioactive glass particles, size range 300-355 microns (BG-particles), in human sinus floor elevations using histomorphometrical methods. A total of 10 patients underwent bilateral grafting, using a 1:1 mixture of autogenous bone particles (from iliac crest) and BG-particles at one side (experimental side), and bone particles only at the other side (control side, split mouth design). A total of 72 bone biopsies were taken at the time of fixture installation; that is, 3 patients at 4 months, 3 at 5 months and 3 at 6 months after grafting and 1 patient at 16 months (when she presented again). In each case 6 biopsies were taken, 3 left and 3 right. Histomorphometry showed that in grafts at control sides, trabecular bone was present after 4 months, comprising almost 41% of the tissue volume. This bone contained viable osteocytes and was of mature lamellar type and showed a mature histological appearance. Bone volume continued to increase slightly, to 42% at 5 months, 44% at 6 months and 45% at 16 months. The graft volume at experimental sides consisted at 4 months for 28% of woven and some lamellar bone, and increased to 35% at 5 months and 38% at 6 months, when mainly lamellar bone was found. At 16 months a lamellar bone volume of 45% was found. The BG-particles transformed and became excavated with time, starting at 4 months, and their centers gradually filled with bone tissue. All BG-particles had disappeared by resorption at 16 months after grafting and had been replaced by bone tissue. Parameters of bone turnover (% osteoid surface, % resorption surface, mineral apposition rate as measured by tetracycline labeling) indicated that bone remodeling was very active at both sides, during more than 6 months, despite the mature histological appearance of the bone tissue. From these histological observations, we conclude that a 1:1 mixture of autogenous bone/BG-particles seems a promising alternative to autogenous bone only, when low amounts of bone tissue are available for sinus augmentation.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">11168226</PMID>
<DateCompleted>
<Year>2001</Year>
<Month>04</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0905-7161</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>11</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2000</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Clinical oral implants research</Title>
<ISOAbbreviation>Clin Oral Implants Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Histological observations on biopsies harvested following sinus floor elevation using a bioactive glass material of narrow size range.</ArticleTitle>
<Pagination>
<MedlinePgn>334-44</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We evaluated the bone augmenting capacity of bioactive glass particles, size range 300-355 microns (BG-particles), in human sinus floor elevations using histomorphometrical methods. A total of 10 patients underwent bilateral grafting, using a 1:1 mixture of autogenous bone particles (from iliac crest) and BG-particles at one side (experimental side), and bone particles only at the other side (control side, split mouth design). A total of 72 bone biopsies were taken at the time of fixture installation; that is, 3 patients at 4 months, 3 at 5 months and 3 at 6 months after grafting and 1 patient at 16 months (when she presented again). In each case 6 biopsies were taken, 3 left and 3 right. Histomorphometry showed that in grafts at control sides, trabecular bone was present after 4 months, comprising almost 41% of the tissue volume. This bone contained viable osteocytes and was of mature lamellar type and showed a mature histological appearance. Bone volume continued to increase slightly, to 42% at 5 months, 44% at 6 months and 45% at 16 months. The graft volume at experimental sides consisted at 4 months for 28% of woven and some lamellar bone, and increased to 35% at 5 months and 38% at 6 months, when mainly lamellar bone was found. At 16 months a lamellar bone volume of 45% was found. The BG-particles transformed and became excavated with time, starting at 4 months, and their centers gradually filled with bone tissue. All BG-particles had disappeared by resorption at 16 months after grafting and had been replaced by bone tissue. Parameters of bone turnover (% osteoid surface, % resorption surface, mineral apposition rate as measured by tetracycline labeling) indicated that bone remodeling was very active at both sides, during more than 6 months, despite the mature histological appearance of the bone tissue. From these histological observations, we conclude that a 1:1 mixture of autogenous bone/BG-particles seems a promising alternative to autogenous bone only, when low amounts of bone tissue are available for sinus augmentation.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tadjoedin</LastName>
<ForeName>E S</ForeName>
<Initials>ES</Initials>
<AffiliationInfo>
<Affiliation>Department of Oral Cell Biology, Academic Center for Dentistry Amsterdam (ACTA), Vrije Universiteit, Amsterdam, van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Lange</LastName>
<ForeName>G L</ForeName>
<Initials>GL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Holzmann</LastName>
<ForeName>P J</ForeName>
<Initials>PJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kulper</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Burger</LastName>
<ForeName>E H</ForeName>
<Initials>EH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D018848">Controlled Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Denmark</Country>
<MedlineTA>Clin Oral Implants Res</MedlineTA>
<NlmUniqueID>9105713</NlmUniqueID>
<ISSNLinking>0905-7161</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001672">Biocompatible Materials</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C073544">Biogran</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018786">Bone Substitutes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015921">Dental Implants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005456">Fluorescent Dyes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>F8VB5M810T</RegistryNumber>
<NameOfSubstance UI="D013752">Tetracycline</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>D</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D020341" MajorTopicYN="N">Absorbable Implants</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001672" MajorTopicYN="N">Biocompatible Materials</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001857" MajorTopicYN="N">Bone Matrix</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016723" MajorTopicYN="N">Bone Remodeling</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001862" MajorTopicYN="N">Bone Resorption</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018786" MajorTopicYN="N">Bone Substitutes</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016025" MajorTopicYN="Y">Bone Transplantation</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003758" MajorTopicYN="N">Dental Implantation, Endosseous</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015921" MajorTopicYN="N">Dental Implants</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005456" MajorTopicYN="N">Fluorescent Dyes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005898" MajorTopicYN="N">Glass</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007575" MajorTopicYN="N">Jaw, Edentulous</DescriptorName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008437" MajorTopicYN="N">Maxilla</DescriptorName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008443" MajorTopicYN="N">Maxillary Sinus</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010011" MajorTopicYN="N">Osteocytes</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010012" MajorTopicYN="N">Osteogenesis</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013752" MajorTopicYN="N">Tetracycline</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2001</Year>
<Month>2</Month>
<Day>13</Day>
<Hour>11</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2001</Year>
<Month>5</Month>
<Day>1</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2001</Year>
<Month>2</Month>
<Day>13</Day>
<Hour>11</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">11168226</ArticleId>
<ArticleId IdType="pii">clr110407</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Pays-Bas</li>
</country>
<region>
<li>Hollande-Septentrionale</li>
</region>
<settlement>
<li>Amsterdam</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Burger, E H" sort="Burger, E H" uniqKey="Burger E" first="E H" last="Burger">E H Burger</name>
<name sortKey="De Lange, G L" sort="De Lange, G L" uniqKey="De Lange G" first="G L" last="De Lange">G L De Lange</name>
<name sortKey="Holzmann, P J" sort="Holzmann, P J" uniqKey="Holzmann P" first="P J" last="Holzmann">P J Holzmann</name>
<name sortKey="Kulper, L" sort="Kulper, L" uniqKey="Kulper L" first="L" last="Kulper">L. Kulper</name>
</noCountry>
<country name="Pays-Bas">
<region name="Hollande-Septentrionale">
<name sortKey="Tadjoedin, E S" sort="Tadjoedin, E S" uniqKey="Tadjoedin E" first="E S" last="Tadjoedin">E S Tadjoedin</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D22 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002D22 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    EdenteV2
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:11168226
   |texte=   Histological observations on biopsies harvested following sinus floor elevation using a bioactive glass material of narrow size range.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:11168226" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a EdenteV2 

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Thu Nov 30 15:26:48 2017. Site generation: Tue Mar 8 16:36:20 2022